Anaphylaxis Management: Critical Updates for UK & Ireland First Aiders

First aiders across the UK and Ireland are urged to familiarise themselves with the latest guidance on managing anaphylaxis, a severe, life-threatening allergic reaction. Recent updates from key regulatory and advisory bodies emphasise the critical importance of prompt recognition and intervention, particularly the correct and timely administration of adrenaline auto-injectors (AAIs).

Anaphylaxis can be triggered by a range of allergens, including food, insect stings, and medications. According to the Anaphylaxis Campaign, there has been a significant increase in hospital admissions for anaphylaxis in the UK over the past decade. The National Institute for Health and Care Excellence (NICE) guidelines (CG134) for anaphylaxis assessment and management are regularly reviewed, as are recommendations from the Resuscitation Council UK (RCUK) and the Irish Health and Safety Authority (HSA).

Key Changes and Emphases in Anaphylaxis Protocol

The core principle of anaphylaxis management remains unchanged: rapid administration of an AAI. However, recent guidance places increased emphasis on several critical areas:

  • Early Recognition: Training now focuses more acutely on identifying the signs of anaphylaxis quickly, which can range from skin rashes and swelling to respiratory distress (wheezing, difficulty breathing) and circulatory collapse (faintness, dizziness). The absence of skin symptoms does not rule out anaphylaxis.
  • Adrenaline Auto-Injector Use: The importance of administering the AAI as the first-line treatment for suspected anaphylaxis, even if symptoms are mild but progressive, is paramount. First aiders are reminded to familiarise themselves with the specific devices (e.g., EpiPen, Jext, Emerade) they may encounter, as administration techniques can vary slightly. The RCUK's 'Guidelines for the Emergency Treatment of Anaphylaxis' provides detailed algorithms for both healthcare professionals and lay first aiders.
  • Post-Administration Care: After administering an AAI, it is crucial to call emergency services immediately (999 in the UK, 112/999 in Ireland), even if the patient appears to recover. Patients should lie down with their legs raised if they are conscious and not experiencing breathing difficulties. If breathing is difficult, they should sit up. If unconscious, they should be placed in the recovery position.
  • Repeat Doses: Guidance from bodies like RCUK confirms that a second dose of adrenaline can be administered after 5-10 minutes if there is no improvement or if symptoms worsen. This highlights the importance of having multiple AAIs available, especially in environments where known allergens are present or individuals with severe allergies are present.
  • Training and Competence: Both the Health and Safety Executive (HSE) in the UK and the HSA in Ireland stress that first aiders administering medication, including AAIs, must be adequately trained and competent. This includes understanding when to administer, how to administer, and what to do afterwards.

Regulatory Context and Workplace Implications

For workplaces, schools, and public venues, these updates have significant implications. Employers in the UK, under the Health and Safety (First-Aid) Regulations 1981, and in Ireland, under the Safety, Health and Welfare at Work Act 2005, have a duty to provide adequate and appropriate first-aid provision. This includes considering the specific risks posed by severe allergies within their environment.

Related training: If you are looking to qualify as a trainer in this area, see AED defibrillator trainer courses or explore PMVA trainer qualifications for nationally recognised UK and Ireland qualifications.

The Department of Health and Social Care in England, for example, has previously issued guidance on the use of AAIs in schools, permitting schools to hold 'spare' AAIs for use in emergencies, even if a child does not have a prescribed device. Similar provisions and best practices are encouraged across both jurisdictions.

First aid training providers are continually updating their curricula to reflect these changes. It is essential for all qualified first aiders to undertake regular refresher training to ensure their knowledge and skills are current and aligned with the latest evidence-based practices and regulatory requirements. This proactive approach can significantly improve outcomes for individuals experiencing anaphylaxis.

For comprehensive and up-to-date first aid training, including specific modules on anaphylaxis management, individuals and organisations should consult reputable providers such as Abertay Training, which offers a range of courses designed to meet UK and Irish regulatory standards. Further information can be found at https://www.abertaytraining.co.uk.